Document is current
Any future updates will be listed below
-
Authors
Lin, Ying-Yu
Esswein, Parker https://orcid.org/0009-0003-4856-2539
Ramirez, Lucas
Warren, Emily https://orcid.org/0000-0001-5839-0222
Nicenboim, Julian
Gerecht, Sharon https://orcid.org/0000-0002-8542-4835
-
Funding
Funding for this research was provided by:
National Aeronautics and Space Administration (TRISH-SNT0101)
U.S. Department of Health & Human Services | NIH | National Eye Institute (EY035853)
National Science Foundation (GRFP)
U.S. Department of Defense (NDSEG)
- License Information
-
More Information
Article History
Received: 2 March 2025
Accepted: 15 May 2026
First Online: 30 June 2026
Ethics
Competing interests: Y.-Y.L., P.E., S.G. and the Duke Office for Translation and Commercialization filed for a US provisional patent (63/893,061) for the derivation and therapeutic and modeling applications of iPSC-derived retinal endothelial cells. All other authors declare no competing interests.
